Geoff Harley

Loading... 2 0 20 0 false
Credit Name
Geoff Harley
Full Name
Harley, Geoff
 
Department
 
Loading... 3 0 20 0 false

Publications

Results 1-6 of 6 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
1Jun-2024The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury.Katerelos, Marina ; Gleich, Kurt; Harley, Geoff ; Loh, Kim; Oakhill, Jonathan S; Kemp, Bruce E; de Souza, David P; Narayana, Vinod K; Coughlan, Melinda T; Laskowski, Adrienne; Ling, Naomi X Y; Murray-Segal, Lisa; Brink, Robert; Lee, Mardiana ; Power, David A ; Mount, Peter F 
22023Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney.Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Lee, Mardiana ; Mount, Peter F ; Power, David A 
31-Sep-2022Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; de Souza, David P; Narayana, Vinod K; Kemp, Bruce E; Power, David A ; Mount, Peter F 
43-Sep-2020Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis.Lee, Mardiana ; Harley, Geoff ; Katerelos, Marina ; Gleich, Kurt; Sullivan, Mitchell A; Laskowski, Adrienne; Coughlan, Melinda; Fraser, Scott A; Mount, Peter F ; Power, David A 
5Jul-2018Use of a new end-stage kidney disease risk calculator in the Kidney Disease Improving Global Outcomes guideline to evaluate the impact of different living kidney donor candidate assessments.Lee, Darren; Manzoor, Momena; Harley, Geoff ; Whitlam, John B ; Cook, Natasha ; Choy, Suet-Wan ; Sandiford, Megan ; Gibson, Charlotte; McMahon, Lawrence P; Roberts, Matthew A
6Jan-2018Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challengeLee, Darren; Whitlam, John B ; Cook, Natasha ; Manzoor, Momena; Harley, Geoff ; Choy, Suet-wan; McMahon, Lawrence P; Roberts, Matthew A